Video creation is increasingly being redefined by artificial intelligence. Tasks that once required hours of manual work—sorting footage, trimming clips, creating subtitles, recording voiceovers, and adapting content for multiple platforms—are
BEIJING – Beijing EasierTong Intelligent Technology Co., Ltd. has announced the launch of internal testing for ImmiClaw, a specialized AI agent solution designed for U.S. employment-based immigration services. Developed in
Every time a bull market has run for a few years, the same conversation starts happening at dinner tables, in trading forums, and on financial television. People start saying things
In celebration of its 10th anniversary in 2026, AlorAir is launching its extended warranty program, marking a decade of innovation in humidity control. Building on a decade of global market
AI-powered IDP cuts cost-per-document from $11.20 to $3.80 and raises straight-through processing rates above 85% within 90 days of deployment — KlearStack document compliance automation platform showing AI processing flow
Congressional candidate Peter Roybal called for greater accountability and leadership transparency during a Los Angeles press conference while also announcing The Committee of Fire Heroes, a coalition focused on rebuilding
Whiteflash offers a curated selection of engagement ring settings from leading brands, giving shoppers the confidence to pair a high-quality diamond with a setting that reflects their personal style and
DelveInsight’s “Opioid Use Disorder Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Opioid Use Disorder pipeline landscape. It covers the Opioid Use
DelveInsight’s, “Bronchiectasis Pipeline Insight 2026” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Bronchiectasis pipeline landscape. It covers the Bronchiectasis pipeline drug profiles, including Bronchiectasis clinical
DelveInsight’s “Multiple Sclerosis Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Multiple Sclerosis pipeline landscape. It covers the Multiple Sclerosis pipeline drug
